Anna-Maija Tolppanen (A-M Tolppanen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 20

Top Topics

Coronary Artery Disease

Cross Sectional

Top Venues

Clinical epidemiology

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Paakinaho, Miia Tiihonen, Heikki Koskela, Marjaana Koponen, Jari Tiihonen, Sirpa Hartikainen, Anna-Maija Tolppanen
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control Study. Clinical epidemiology 15 (2023)
Laura Latvala, Miia Tiihonen, Teemu J Murtola, Sirpa Hartikainen, Anna-Maija Tolppanen
Use of α1-adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease. Pharmacoepidemiology and drug safety 31 (10) (2022)
Katriina Sunnarborg, Miia Tiihonen, Marjo Huovinen, Marjaana Koponen, Sirpa Hartikainen, Anna-Maija Tolppanen
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes. Pharmacoepidemiology and drug safety 31 (8) (2022)
Marjaana Koponen, Anne Paakinaho, Julian Lin, Sirpa Hartikainen, Anna-Maija Tolppanen
Identification of Drugs Associated with Lower Risk of Parkinson's Disease Using a Systematic Screening Approach in a Nationwide Nested Case-Control Study. Clinical epidemiology 14 (2022)
Tomi Kuusimäki, Haidar Al-Abdulrasul, Samu Kurki, Jarmo Hietala, Sirpa Hartikainen, Marjaana Koponen, Anna-Maija Tolppanen, Valtteri Kaasinen
Increased Risk of Parkinson's Disease in Patients With Schizophrenia Spectrum Disorders. Movement disorders : official journal of the Movement Disorder Society 36 (6) (2021)
Anniina Tarvainen, Sirpa Hartikainen, Heidi Taipale, Antti Tanskanen, Marjaana Koponen, Anna-Maija Tolppanen
Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease. International journal of geriatric psychiatry 36 (7) (2021)
Federica Pisa, Jonas Reinold, Piia Lavikainen, Marjaana Koponen, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Anna-Maija Tolppanen
Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clinical epidemiology 13 (2021)
Blair Rajamaki, Sirpa Hartikainen, Anna-Maija Tolppanen
Psychotropic Drug-Associated Pneumonia in Older Adults. Drugs & aging 37 (4) (2020)
Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen, Jari Tiihonen, Sirpa Hartikainen
Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease. BMC geriatrics 20 (1) (2020)
Vesa Tapiainen, Piia Lavikainen, Marjaana Koponen, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Anna-Maija Tolppanen
The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease. Journal of the American Geriatrics Society 68 (3) (2020)
Nina Kristiina Mattsson, Päivi K Karjalainen, Anna-Mari Heikkinen, Kari Nieminen, Jyrki Jalkanen, Anna-Maija Tolppanen
Agreement between patient global impression scale of improvement, pelvic floor distress inventory and 15D in measuring the outcome of pelvic organ prolapse surgery. Neurourology and urodynamics 39 (8) (2020)
Sarianna Ilmaniemi, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Anna-Maija Tolppanen
Incidence of head injury and traumatic brain injury among people with Alzheimer's disease. Journal of epidemiology and community health 73 (5) (2019)
Nina Kristiina Mattsson, Päivi K Karjalainen, Anna-Maija Tolppanen, Anna-Mari Heikkinen, Jyrki Jalkanen, Päivi Härkki, Kari Nieminen
Methods of surgery for pelvic organ prolapse in a nationwide cohort (FINPOP 2015). Acta obstetricia et gynecologica Scandinavica 98 (4) (2019)
Anna-Maija Tolppanen, Miia Tiihonen, Heidi Taipale, Marjaana Koponen, Antti Tanskanen, Piia Lavikainen, Jari Tiihonen, Sirpa Hartikainen
Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study. Drugs & aging 35 (11) (2019)
Jari Heiskanen, Juha Hartikainen, Janne Martikainen, Heikki Miettinen, Mikko Hippeläinen, Risto P Roine, Anna-Maija Tolppanen
Purchases of medical therapy recommended for coronary artery disease before and after elective revascularisation. European journal of clinical pharmacology 76 (1) (2019)
Vesa Tapiainen, Heidi Taipale, A Tanskanen, J Tiihonen, S Hartikainen, Anna-Maija Tolppanen
The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study. Acta psychiatrica Scandinavica 138 (2) (2018)
Anna-Maija Tolppanen, Ari Voutilainen, Heidi Taipale, Antti Tanskanen, Piia Lavikainen, Marjaana Koponen, Jari Tiihonen, Sirpa Hartikainen
Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PloS one 12 (3) (2017)
Anna-Maija Tolppanen, Heidi Taipale, Marjaana Koponen, Antti Tanskanen, Piia Lavikainen, Jussi Paananen, Jari Tiihonen, Sirpa Hartikainen
Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. Pharmacoepidemiology and drug safety 26 (8) (2017)
Anna-Maija Tolppanen, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen
Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. BMC geriatrics 16 (1) (2016)
Anna-Maija Tolppanen, Riitta Ahonen, Marjaana Koponen, Piia Lavikainen, Maija Purhonen, Heidi Taipale, Antti Tanskanen, Jari Tiihonen, Miia Tiihonen, Sirpa Hartikainen
Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study. Journal of preventive medicine and public health = Yebang Uihakhoe chi 49 (2) (2016)